| Company Name: |
Alfa Chemistry |
| Tel: |
+1-5166625404; |
| Email: |
Info@alfa-chemistry.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
|
| | adenosine(5')tetraphosphate uridine Basic information |
| Product Name: | adenosine(5')tetraphosphate uridine | | Synonyms: | adenosine(5')tetraphosphate uridine;Adenosine 5'-(pentahydrogen tetraphosphate), P'''→5'-ester with uridine;Diquafosol Sodium Impurity-AP4U;Diquafosol Impurity-AP4U;P1,P4-(Adenosine-5'-uridine-5') tetraphosphate | | CAS: | 10527-48-7 | | MF: | C19H27N7O21P4 | | MW: | 813.35 | | EINECS: | | | Product Categories: | | | Mol File: | 10527-48-7.mol |  |
| | adenosine(5')tetraphosphate uridine Chemical Properties |
| density | 2.53±0.1 g/cm3(Predicted) | | pka | 0.70±0.50(Predicted) |
| | adenosine(5')tetraphosphate uridine Usage And Synthesis |
| Uses | Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 receptor and possibly through the P2Y2 and P2Y4 receptors. Uridine adenosine tetraphosphate can be used in the study of cardiovascular diseases[1]. | | References | [1] Jankowski, et al. "Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor." Nature medicine 11.2 (2005): 223-227. DOI:10.1038/nm1188 |
| | adenosine(5')tetraphosphate uridine Preparation Products And Raw materials |
|